Oral health

Folate and gingivitis: why low folate worsens gum inflammation and what the evidence shows

Folate is critical for the rapid cell division that keeps gum tissue healthy. When it is low, gums become more inflamed and slower to heal. Here is what the randomised trial evidence shows.

At a glance	What the evidence shows
Does low folate worsen gingivitis?	Yes. Deficiency raises gingival index and bleeding scores independent of plaque level.
Best-evidenced treatment?	Topical folate mouthwash (about 5 mg/day) in at-risk groups.
Who is most at risk?	Pregnant women, users of phenytoin, valproate or methotrexate, heavy drinkers, malabsorbers.
Preferred supplement form?	5-MTHF (L-methylfolate) if the MTHFR C677T variant is present; otherwise folic acid works.
Most reliable food sources?	Beef liver, lentils, chickpeas, spinach, asparagus, Brussels sprouts.
Does folate replace dental care?	No. It supports tissue resilience but does not remove plaque or replace cleaning.

Why gum tissue is particularly dependent on folate

The gingival (gum) epithelium turns over every 7 to 14 days, requiring a consistent supply of the building blocks for DNA synthesis. Folate is the central player, providing the methyl group transfers needed for nucleotide synthesis (specifically thymidylate synthesis from deoxyuridylate, and purine synthesis). When folate is insufficient, DNA synthesis is impaired, cells accumulate DNA strand breaks, fail to complete mitosis normally, and undergo apoptosis at higher rates. The result is a thinner, less intact epithelial barrier with impaired wound healing capacity.

In addition to epithelial effects, folate is important for immune cell function. Neutrophils, the first responders to periodontal infection, require folate for their rapid proliferation during immune activation. Folate-deficient individuals show impaired neutrophil function in some studies, which is relevant because neutrophil phagocytosis of periodontal bacteria is an important defence mechanism at the gingival sulcus.

To understand why this matters for gums specifically, it helps to compare tissue turnover rates. The gut lining renews in 3 to 5 days, the skin in roughly 28 days, and most connective tissue far more slowly. The oral and gingival epithelium sits near the fast end of that spectrum, and any tissue that divides quickly is the first to feel a shortage of a nutrient needed for division. This is the same reason the earliest signs of folate deficiency often appear in the mouth and blood, both of which contain rapidly dividing cell populations, before they show up anywhere else.

There is also a vascular and structural dimension. Healthy gingiva relies on a tightly organised layer of epithelial cells sitting on a basement membrane, sealed against the tooth by the junctional epithelium. When cell production cannot keep pace with normal shedding, that seal becomes leakier. Bacterial products from plaque, such as lipopolysaccharide, penetrate more easily and trigger a stronger inflammatory response. So a folate shortage does not create inflammation out of nothing; it lowers the threshold at which the same amount of plaque produces visible, bleeding, inflamed gums.

This is the mechanistic reason the clinical trials consistently separate two measurements: the plaque index (how much bacterial film is present) and the gingival index (how inflamed the tissue is). When folate changes the gingival index without changing the plaque index, it is strong evidence that the vitamin is acting on the host tissue itself rather than on the bacteria.

The folate biochemistry behind gum health

Folate sits at the centre of what biochemists call one-carbon metabolism, the network of reactions that shuttle single-carbon units around the cell. Two outputs of that network matter most for gum tissue. The first is thymidylate synthesis: converting deoxyuridine monophosphate (dUMP) into deoxythymidine monophosphate (dTMP), one of the four building blocks of DNA. Without adequate folate, cells substitute uracil for thymine during DNA replication, which leads to error-prone repair, double-strand breaks, and cell death. The second output is purine synthesis, which supplies the adenine and guanine bases. A tissue that has to build a fresh genome for millions of new cells every day cannot do so if either supply falls short.

Folate is also the vitamin that regenerates methionine from homocysteine, using 5-MTHF as the methyl donor in a reaction that also requires vitamin B12. This has two consequences. It keeps homocysteine, a pro-inflammatory and vasculotoxic amino acid, from accumulating; elevated homocysteine has been associated with more severe periodontitis in several observational studies. And it maintains the supply of S-adenosylmethionine (SAMe), the universal methyl donor used to methylate DNA and regulate which genes are switched on. Disrupted methylation patterns in inflamed gingival tissue are an active area of periodontal research.

The practical takeaway from the biochemistry is that folate does not act alone. It works in a tightly coupled cycle with vitamin B12, vitamin B6, and riboflavin (the cofactor for the MTHFR enzyme). A shortage of B12, for example, can trap folate in an unusable form, the so-called methyl-folate trap, producing a functional folate deficiency even when blood folate looks adequate. This is why sensible advice about folate and gum health almost always sits inside broader advice about B-vitamin status rather than treating folate as a single magic input.

How folate deficiency shows up in the mouth

Because the oral mucosa renews so quickly, the mouth is one of the earliest places folate deficiency becomes visible. The classic sign is glossitis: a smooth, red, sore tongue where the small papillae have flattened, sometimes described by patients as a burning or raw sensation. Angular cheilitis, cracking and inflammation at the corners of the mouth, is another common finding, though it also occurs with iron and B12 deficiency and with fungal overgrowth. Recurrent aphthous ulcers (canker sores) are frequently reported in people with low folate, iron, or B12, and correcting the underlying deficiency reduces their frequency in a subset of sufferers.

At the gum line specifically, the picture is redness, swelling, and a tendency to bleed on brushing or probing that is out of proportion to the amount of visible plaque. The tissue may look glossy and feel tender. None of these signs is unique to folate deficiency, which is the key clinical caveat: a red, bleeding gum is far more often caused by ordinary plaque-induced gingivitis than by a vitamin shortage. Folate should be considered as a contributing factor, particularly when someone is in a high-risk group, when oral signs persist despite good plaque control, or when other mucosal signs such as glossitis appear alongside the gum changes.

This is why the honest framing is that folate status modifies how gums respond to plaque, rather than being a standalone cause of gum disease. If the plaque is not being removed, no amount of folate will keep the gums healthy. But in someone who is folate-depleted, the same brushing routine buys less protection, and closing the nutritional gap can be the difference between gums that settle down and gums that stay inflamed.

The clinical evidence: topical folate mouthwash trials

The most interesting body of evidence on folate and gums is not about swallowing supplements but about rinsing with them. A cluster of controlled trials from the late 1970s and 1980s tested folate applied directly to the gums as a mouthwash, and the pattern that emerged is remarkably consistent: topical folate reduces gingival inflammation without necessarily reducing plaque.

Vogel et al. (1976 to 1978), gingival health: An early double-blind crossover trial in adults with established gingivitis found the folate mouthwash group showed significantly reduced gingival index scores compared to placebo, with no significant difference in plaque index scores. This dissociation, better gums with the same plaque, is the finding that launched the whole line of research and pointed to a direct effect on gingival tissue responsiveness rather than an antibacterial effect.

Pack and Thomson (1980), pregnancy: Tested topical folate mouthwash in pregnant women, a group with both elevated folate requirements and a hormonally amplified inflammatory response. The folate mouthwash group showed significantly lower gingival index and bleeding scores than placebo at follow-up, while plaque scores were similar between groups. Notably, the same research reported that systemic (swallowed) folate supplementation did not produce the same gingival benefit in this population, sharpening the case that the topical route is doing something local.

Drew et al. (1987), phenytoin users: Examined the effect of folate mouthwash in people taking phenytoin, an anticonvulsant notorious for causing gingival overgrowth. Topical folate significantly reduced gingival inflammation scores compared to placebo. Later studies using systemic oral folate supplementation have shown less consistent results, again suggesting the topical route may be more effective for the inflammatory component.

Why might topical beat systemic? The leading explanation is concentration at the target. A mouthwash bathes the gingival epithelium in a high local dose of folate that the tissue can take up directly, whereas a swallowed dose is diluted across the whole body and, in a well-nourished person, may not raise local tissue levels much above baseline. It also means the benefit is likely to be largest in people who are actually short of folate; in someone already replete, adding more, by any route, has less room to help.

The evidence is not without limits. Most of these trials are small (dozens of participants), several decades old, and use varying folate concentrations and rinse durations. There has been relatively little large, modern replication. So the fair summary is: consistent, biologically plausible, and clinically promising signals, especially in at-risk groups, but not the kind of large multi-centre trial base that would let anyone make sweeping claims. The table below distils how the two delivery routes compare.

Feature	Topical folate mouthwash	Systemic (oral) folate
Primary target	Local gingival epithelium	Whole-body folate status
Effect on gingival index	Consistent reduction in trials	Inconsistent, weaker in the replete
Effect on plaque index	Little to none (not antibacterial)	Little to none
Best-evidenced groups	Pregnancy, phenytoin users	People with true dietary deficiency
Also corrects body-wide deficiency?	No, local only	Yes, this is its main role

Pregnancy, hormones, and folate-related gingivitis

Pregnancy gingivitis affects an estimated 35-100% of pregnant women. Folate requirements increase substantially during pregnancy: the recommended daily intake rises from approximately 400 mcg DFE to 600 mcg DFE per day. Many women enter pregnancy with borderline folate stores, and hormonal changes amplify gingival inflammatory response. The combination explains why pregnant women show particularly clear benefits from topical folate application in clinical trials.

The hormonal mechanism is worth spelling out. Rising progesterone and oestrogen increase the permeability of gingival blood vessels and shift the local immune response, making the tissue more reactive to the same bacterial load. Progesterone also encourages the growth of certain periodontal bacteria such as Prevotella intermedia. On top of that heightened baseline reactivity, a folate shortage slows the epithelial repair that would normally keep the tissue intact. So pregnancy stacks two pressures on the gums at once, which is why it is both the group most likely to develop gingivitis and the group in which topical folate has shown the clearest benefit.

There is an important safety framing here. Every major guideline already recommends folic acid before and during early pregnancy, at around 400 to 600 mcg per day, to reduce the risk of neural tube defects. Gum health is a secondary benefit that comes along for the ride, not a reason to take doses beyond what is advised. Pregnant women should follow their obstetric provider guidance on folate and raise any persistent gum bleeding with their dentist, who can safely provide a cleaning and, where appropriate, discuss a topical folate rinse.

Drug-nutrient interactions: anticonvulsants and methotrexate

Phenytoin reduces folate absorption and increases catabolism, causing drug-induced gingival overgrowth in up to 50% of users. Folate supplementation does not prevent gingival overgrowth but does reduce the inflammatory component. Valproate and carbamazepine similarly reduce folate status. Methotrexate is a folate antagonist; folic acid supplementation on the day after low-dose methotrexate administration is standard practice to reduce mucosal side effects including oral mucositis.

The phenytoin story deserves a careful distinction, because it is easy to conflate two different things. Phenytoin causes gingival overgrowth, a physical enlargement of the gum tissue driven by the drug effect on fibroblasts and collagen. That overgrowth is largely a mechanical, drug-specific phenomenon, and folate does not reverse it. What folate does help is the inflammation layered on top of the overgrown tissue, which is harder to keep clean and therefore accumulates plaque. Reducing that inflammatory component makes the tissue less red and less prone to bleeding, and it is this component that the topical folate trials targeted. Anyone on long-term phenytoin should have meticulous professional cleaning regardless, because plaque control is the single biggest lever on how bad the overgrowth becomes.

Methotrexate is a different mechanism again. It deliberately blocks dihydrofolate reductase to slow rapidly dividing cells, which is useful in rheumatoid arthritis and cancer but also hits the fast-dividing cells of the mouth, producing sores and mucositis. The standard fix is the counterintuitive one: prescribing folic acid alongside low-dose methotrexate reduces mucosal and gastrointestinal side effects without abolishing the drug benefit, and it is now routine rheumatology practice. The critical caveat is that folate timing and dosing here are a medical decision, set by the prescriber, and patients should never self-adjust folate around methotrexate.

MTHFR polymorphism and folate bioavailability

The MTHFR enzyme converts folic acid into 5-methyltetrahydrofolate (5-MTHF), the active circulating form of folate. The common C677T variant is present homozygously in approximately 10% of Northern European populations and heterozygously in 35-40%. People with reduced MTHFR activity may maintain folate status more reliably with supplements providing pre-converted 5-methylfolate (L-methylfolate or (6S)-5-MTHF) rather than standard folic acid.

A sense of proportion helps here, because MTHFR testing has been heavily oversold by some supplement marketers. Having the C677T variant does not mean a person cannot use folic acid at all; the homozygous TT genotype reduces enzyme activity substantially but not to zero, and most people with the variant maintain normal folate levels on an ordinary diet, especially where food is fortified. The variant matters more when folate intake is marginal, when homocysteine is elevated, or when someone is trying to correct a deficiency efficiently. In those situations, choosing the pre-converted 5-MTHF form removes the conversion bottleneck and is a reasonable, low-risk choice.

For most readers the practical message is simple: you do not need a genetic test to eat folate-rich foods or to take a standard prenatal or B-complex supplement. If you already know you carry the variant, or if blood work shows persistently high homocysteine despite adequate intake, that is when switching to 5-MTHF is worth discussing with a clinician. The comparison table below lays out how the main folate forms differ.

Folate form	Source	Needs MTHFR conversion?	Best for
Food folate	Greens, legumes, liver	Partial	Everyone, baseline intake
Folic acid	Fortified food, supplements	Yes, full conversion	General supplementation, pregnancy
5-MTHF (L-methylfolate)	Specialised supplements	No, already active	MTHFR variant, high homocysteine

How folate deficiency is diagnosed

If gum problems raise the question of folate status, the answer comes from blood work, not from the gums themselves. The most common first test is serum folate, which reflects recent intake and can swing with a single folate-rich meal. A more stable marker is red blood cell (RBC) folate, which reflects folate stores over the previous few months and is less influenced by what you ate yesterday. Because folate and vitamin B12 deficiencies produce overlapping blood and mucosal signs, clinicians almost always check B12 at the same time, since treating a folate deficiency while missing a B12 deficiency can worsen the neurological damage of the latter.

Homocysteine is a useful functional marker: it rises when folate (or B12 or B6) is insufficient at the tissue level, sometimes before serum folate looks clearly low. Elevated homocysteine alongside low-normal folate is a signal that intake is marginal for that person. A full blood count can also point toward deficiency, since both folate and B12 shortages cause macrocytic anaemia, where red cells become abnormally large, another consequence of impaired DNA synthesis in a fast-dividing cell line. None of this is something to interpret alone; the point of listing it is so readers know what to ask their doctor for rather than guessing from symptoms.

Folate-rich foods and dietary adequacy

Rich dietary sources include beef liver (approximately 215 mcg per 75 g serving, more than half the adult RDA), cooked lentils (approximately 180 mcg per 100 g), cooked chickpeas and black beans (100-150 mcg per 100 g), spinach cooked (approximately 130 mcg per 100 g), asparagus (approximately 90 mcg per 100 g), and Brussels sprouts and broccoli (50-80 mcg per 100 g cooked). Folate is heat-sensitive, so brief steaming and using cooking water for soups improves retention.

Food	Typical folate	Share of 400 mcg RDA
Beef liver (75 g)	~215 mcg	~54%
Cooked lentils (100 g)	~180 mcg	~45%
Cooked spinach (100 g)	~130 mcg	~33%
Chickpeas / black beans (100 g)	100-150 mcg	25-38%
Asparagus (100 g)	~90 mcg	~23%
Broccoli / Brussels sprouts (100 g)	50-80 mcg	13-20%

The name folate literally comes from the Latin folium, meaning leaf, and that is the simplest mental model: leaves and legumes first. A person who eats a serving of legumes and a serving of cooked greens most days is unlikely to be folate-deficient. The cooking caveat is real, though. Folate is water-soluble and heat-sensitive, and prolonged boiling can destroy 40 percent or more of the folate in a vegetable and leach much of the rest into the water. Steaming, quick sauteing, or eating some produce raw preserves more, and if you do boil, keeping the cooking liquid for a soup or sauce recovers what leached out.

In many countries, mandatory folic acid fortification of flour and grain products has quietly raised baseline intake and made severe dietary folate deficiency uncommon in the general population. That is why the at-risk framing throughout this article matters: the people who still get into trouble are those with higher requirements (pregnancy), higher losses or blocked metabolism (certain medications, heavy alcohol use), or impaired absorption (coeliac disease, inflammatory bowel disease, bariatric surgery), rather than the average well-fed adult.

How much folate you actually need

The recommended intake for most adults is 400 mcg DFE per day, rising to 600 mcg DFE in pregnancy and 500 mcg DFE during breastfeeding. The DFE unit exists because folic acid from supplements and fortified food is absorbed more efficiently than folate from whole foods: 1 mcg of food folate counts as 1 mcg DFE, but 1 mcg of folic acid taken on an empty stomach counts as 2 mcg DFE. That distinction matters when reading labels, because a supplement listing 400 mcg of folic acid is delivering closer to 680 mcg DFE.

There is also an upper limit worth respecting. The tolerable upper intake level for folic acid (the synthetic form) is set at 1000 mcg per day for adults, chiefly because very high folic acid intake can mask the anaemia of vitamin B12 deficiency while the neurological damage of that deficiency progresses unchecked. This limit applies to folic acid, not to food folate, which has no established upper limit. For gum health specifically, there is no evidence that pushing intake above the recommended amounts adds benefit in someone who is already replete, which reinforces the theme that folate helps most where it was previously short.

A practical folate-and-gums protocol

Pulling the evidence together into something you can act on, the sensible order of operations looks like this. First, control plaque, because that is the dominant cause of gingivitis and no nutrient substitutes for it: brush twice daily with a soft brush, clean between the teeth daily, and keep regular professional cleanings. Second, cover folate from food by making legumes and cooked greens a near-daily habit, cooked gently to preserve the vitamin. Third, identify whether you are in an at-risk group, pregnancy, anticonvulsant or methotrexate use, heavy alcohol intake, or a malabsorption condition, because that is where a shortfall is plausible and where correcting it has the most documented payoff.

Fourth, if you are at risk or your gums stay inflamed despite good hygiene, ask your doctor to check serum or RBC folate (and B12), rather than supplementing blindly. Fifth, if supplementation is indicated, a standard folic acid dose covers most people, while 5-MTHF is the reasonable choice for those with the MTHFR variant or elevated homocysteine. Sixth, if you fall into one of the trial-supported groups, particularly pregnancy or phenytoin use, a topical folate mouthwash is worth raising with your dentist, since that is where the local anti-inflammatory evidence is strongest. Throughout, treat folate as one layer of gum health rather than the whole strategy: it improves how resilient the tissue is, but the plaque still has to come off.

What folate cannot do

In the interest of saying plainly what a product or nutrient cannot do: folate does not remove plaque, does not cure established periodontitis, and will not fix bleeding gums that are caused by inadequate cleaning. It does not reverse phenytoin-induced gingival overgrowth, and it is not a substitute for a dental visit when gums are persistently inflamed, since that pattern can also signal periodontitis that needs professional treatment. In well-nourished people with no deficiency, adding extra folate has not been shown to improve gum health, and megadosing carries its own risk of masking B12 deficiency.

What folate can do is make the gum tissue more resilient by supplying the raw material for the fast cell turnover and immune response the gums depend on, and, applied topically in people who are short of it, measurably reduce inflammation in controlled trials. That is a genuine and useful effect, held in its proper place: a supporting layer beneath good daily hygiene and regular dental care, not a replacement for either.

Frequently asked questions